MIRA Pharmaceuticals Stock Forward View
| MIRA Stock | 1.20 0.01 0.83% |
MIRA Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast MIRA Pharmaceuticals stock prices and determine the direction of MIRA Pharmaceuticals Common's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of MIRA Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, the relative strength index (RSI) of MIRA Pharmaceuticals' share price is approaching 32. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling MIRA Pharmaceuticals, making its price go up or down. Momentum 32
Sell Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.05) | EPS Estimate Current Year (1.17) | EPS Estimate Next Year (0.41) | Wall Street Target Price 17.75 | EPS Estimate Current Quarter (0.08) |
Using MIRA Pharmaceuticals hype-based prediction, you can estimate the value of MIRA Pharmaceuticals Common from the perspective of MIRA Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of MIRA Pharmaceuticals Common on the next trading day is expected to be 1.13 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 1.69. MIRA Pharmaceuticals after-hype prediction price | USD 1.22 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of MIRA Pharmaceuticals to cross-verify your projections. MIRA Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine MIRA price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for MIRA using various technical indicators. When you analyze MIRA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
MIRA Pharmaceuticals Cash Forecast
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the MIRA Pharmaceuticals' financial statements to predict how it will affect future prices.
Cash | First Reported 2010-12-31 | Previous Quarter 3.3 M | Current Value 2.3 M | Quarterly Volatility 1.5 M |
MIRA Pharmaceuticals Naive Prediction Price Forecast For the 4th of February
Given 90 days horizon, the Naive Prediction forecasted value of MIRA Pharmaceuticals Common on the next trading day is expected to be 1.13 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.69.Please note that although there have been many attempts to predict MIRA Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that MIRA Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
MIRA Pharmaceuticals Stock Forecast Pattern
| Backtest MIRA Pharmaceuticals | MIRA Pharmaceuticals Price Prediction | Research Analysis |
MIRA Pharmaceuticals Forecasted Value
In the context of forecasting MIRA Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. MIRA Pharmaceuticals' downside and upside margins for the forecasting period are 0.01 and 3.98, respectively. We have considered MIRA Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of MIRA Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent MIRA Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.4239 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0276 |
| MAPE | Mean absolute percentage error | 0.019 |
| SAE | Sum of the absolute errors | 1.6859 |
Predictive Modules for MIRA Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MIRA Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.MIRA Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of MIRA Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in MIRA Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of MIRA Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
MIRA Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting MIRA Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on MIRA Pharmaceuticals' historical news coverage. MIRA Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.06 and 4.07, respectively. We have considered MIRA Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
MIRA Pharmaceuticals is slightly risky at this time. Analysis and calculation of next after-hype price of MIRA Pharmaceuticals is based on 3 months time horizon.
MIRA Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as MIRA Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MIRA Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with MIRA Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.35 | 2.85 | 0.01 | 0.02 | 4 Events / Month | 6 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.20 | 1.22 | 0.83 |
|
MIRA Pharmaceuticals Hype Timeline
MIRA Pharmaceuticals is now traded for 1.20. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of -0.02. MIRA is projected to increase in value after the next headline, with the price projected to jump to 1.22 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.83%, whereas the daily expected return is now at -0.35%. The volatility of related hype on MIRA Pharmaceuticals is about 4191.18%, with the expected price after the next announcement by competition of 1.18. Net Loss for the year was (7.85 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next projected press release will be in about 4 days. Check out Historical Fundamental Analysis of MIRA Pharmaceuticals to cross-verify your projections.MIRA Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to MIRA Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict MIRA Pharmaceuticals' future price movements. Getting to know how MIRA Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how MIRA Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MYO | Myomo Inc | (0.03) | 10 per month | 0.00 | (0.03) | 8.79 | (7.61) | 21.89 | |
| TLPH | Talphera | 0.04 | 8 per month | 0.00 | (0.09) | 6.90 | (9.22) | 32.54 | |
| APUS | Apimeds Pharmaceuticals US | (0.28) | 8 per month | 8.81 | 0.02 | 15.05 | (20.79) | 59.03 | |
| POCI | Precision Optics | 0.06 | 7 per month | 2.30 | 0.07 | 3.68 | (3.55) | 27.89 | |
| MLSS | Milestone Scientific | 0.02 | 10 per month | 0.00 | (0.16) | 7.41 | (6.90) | 23.59 | |
| IGC | India Globalization Capital | 0.04 | 5 per month | 0.00 | (0.16) | 6.06 | (6.06) | 25.10 | |
| MODD | Modular Medical | (0.01) | 9 per month | 6.82 | 0 | 10.42 | (8.11) | 45.40 | |
| ANTX | AN2 Therapeutics | 0.02 | 9 per month | 0.00 | (0.06) | 4.55 | (4.62) | 32.31 | |
| NNVC | NanoViricides | (0.11) | 40 per month | 0.00 | (0.08) | 9.91 | (8.60) | 34.35 | |
| QTTB | Q32 Bio | (0.43) | 7 per month | 4.68 | 0.1 | 7.51 | (8.54) | 85.16 |
Other Forecasting Options for MIRA Pharmaceuticals
For every potential investor in MIRA, whether a beginner or expert, MIRA Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. MIRA Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in MIRA. Basic forecasting techniques help filter out the noise by identifying MIRA Pharmaceuticals' price trends.MIRA Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MIRA Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of MIRA Pharmaceuticals could also be used in its relative valuation, which is a method of valuing MIRA Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
MIRA Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how MIRA Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MIRA Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying MIRA Pharmaceuticals stock market strength indicators, traders can identify MIRA Pharmaceuticals Common entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 1.2 | |||
| Day Typical Price | 1.2 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) | |||
| Relative Strength Index | 32.26 |
MIRA Pharmaceuticals Risk Indicators
The analysis of MIRA Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in MIRA Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting mira stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.23 | |||
| Standard Deviation | 2.96 | |||
| Variance | 8.74 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for MIRA Pharmaceuticals
The number of cover stories for MIRA Pharmaceuticals depends on current market conditions and MIRA Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that MIRA Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about MIRA Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
MIRA Pharmaceuticals Short Properties
MIRA Pharmaceuticals' future price predictability will typically decrease when MIRA Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of MIRA Pharmaceuticals Common often depends not only on the future outlook of the potential MIRA Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MIRA Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 15.4 M | |
| Cash And Short Term Investments | 2.8 M |
Check out Historical Fundamental Analysis of MIRA Pharmaceuticals to cross-verify your projections. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MIRA Pharmaceuticals. Expected growth trajectory for MIRA significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive MIRA Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding MIRA Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects MIRA's accounting equity. The concept of intrinsic value—what MIRA Pharmaceuticals' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push MIRA Pharmaceuticals' price substantially above or below its fundamental value.
Understanding that MIRA Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MIRA Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, MIRA Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.